phase readout
saveNCT04969835: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Avacta Life Sciences Ltd. Phase: PHASE1. Conditions: Salivary Gland Tumor, Urothelial Carcinoma, Ovarian Carcinoma, Breast Cancer, Soft Tissue Sarcoma
view source ↗
comments(0)
5-min edit window · permanent after that